May 3,  2012  30  US 2012/0108878  Al  of different buffers and buffer concentrations to optimize the  rate of chemical activation of perhydrolysis by different buff› ers to identify the preferred mode of the invention. In the  present invention, the reference standards were established  for the purpose of creating formulations with optimum: (i)  rates of perhydrolysis of the percarboxylic acid sources; (ii)  stocihiometries of activator and reactive species for maxi› mum activated life (pot life); and (iii) optimum efficacy  against known threat loads oftoxants. Establishing such ref› erence standards against which the efficacy of other formu› lations could be compared was an important invention.  [0270]  In the preferred embodiments of the present inven› tion, the method of chemical activation is not a simple pH  adjustment with a base, but instead is an activation by a  buffering system in which the buffering capacity is used to  establish the quasi-steady state equilibrium of reactive spe› cies production as described above. A second aspect of the  preferred embodiment of the invention is that the stoichiom› etry of the activator and reactive oxygen species is optimized  to provide the greatest rate and efficacy in reducing threat  loads of chemical or biological toxants. In yet a third aspect of  the preferred embodiment of the invention, the kit configura› tion is binary. It is yet a fourth aspect of the preferred embodi› ment of the invention that such a kit would have a small  logistical footprint. A fifth aspect of the preferred embodi› ment of the invention is that it can be readily aerosolized as a  spray. A sixth aspect of the preferred embodiment of the  invention is a formulation that is easy and safe to ship, store,  use, and cleanup. Finally, a preferred embodiment of the  invention is that the formulation is environmentally safe to  use and has excellent materials compatibility.  [0271]  The invention also relates to a quaternary kit  1300  comprising a kit container  1310  for the components to pre› pare a chemical or biological decontaminant solution. The kit  container  1310  can be, but is not limited to, a suitcase, a box,  or a bucket-type kit container. The kit container  1310  can be  opaque or transparent.  If  transparent, an end user is able to  determine if the kit  1300  contains the exact components  desired. The kit can comprise at least at least one polar  organic amphipathic solvent Base Mix  1320,  at least one dry  or liquid activators or sources thereof,  1330  and  1340,  and at  least one liquid or dry reactive oxygen species,  1350.  The  solvent can be a polar aprotic solvent, a polar-protic solvent,  or combinations thereof. Further, the solvent can be a nitrile,  a ketone, an aldehyde, a carboxylic acid, an amide, a furan, an  alkanol or a polyol. The volume fraction of water in decon› taminant solution can range from about 25% to about 80% or  from about 25% to about 75%, and the pH of the solution can  be less than or equal to about 8.5. More specifically, the polar  amphipathic solvents can be butanediol, an isomer ofbutane› diol, 1-hexanol, a linear or branched-chain alcohol with 1 to  15 carbons, an n-alcohol, a butoxy-alcohol, or a combination  thereof. The active oxygen species can be tetraacetylethyl› enediamine  (TAED)  or  tetraacetylmethylenediamine  (TAMD). Alternatively, the pH can be maintained at less than  or equal to about 8.0. The invention is active against all agents  as pH values between about 7.0 to about 10.5; the buffer  capacity is more effective at pH values between about 8.0 to  about 9.0. However, for maximum active life, the preferred  embodiment is maintained a pH values from about 8.0 to  about 8.5. The pH can further be maintained at a pH of about  8.5.  [0272]  The at least one liquid or  dry  activator  1330, 1340  of  the quaternary kit can comprise any peroxide or persulfate  which is the source in the decontaminant solution of hydroxyl  radicals, hydroxyl ions, super oxides, or other oxidizers,  which perhydrolyze the reactive oxygen species source. In  addition, the at least one reactive oxygen species  1350  can  comprise peroxyacetic acid or its source, a first activator  1330  that is a hydrogen peroxide activator and a second activator  1340  that comprises a buffer system, which includes, but is  not limited to, carbonate or sodium hydroxide based buffer  systems. The kit of the invention can further comprise a block  co-polymer, which would be pre-mixed with the base mix  solvent  1320,  wherein the block co-polymer can be ethylene  oxide and propylene oxide co-polymer that terminates in  primary hydroxyl groups.  [0273]  The quaternary kit can also comprise a container  1360  for mixing the solution, the at least one solvent  1320,  at  least one  dry  or liquid activator or source thereof  1330, 1340,  and at least one reactive oxygen species  1350,  which can be  combined together into a decontamination mixture, along  with means for physically associating the decontamination  mixture with the toxant. The quarternary kit  1310  can use a  wide variety of materials to store the components of the  system, such as vessels made ofbut not limited to, metal, clear  glass, colored glass or plastic.  [0274]  The means for physically associating the decon› tamination mixture with the toxant can comprise an applica› tor  1380  including, but not limited to, an aerosolization  nozzle. The kit container  1310  can comprise a handle  1370  for  carrying the kit container with components. The kit container  1310  can also comprise wheels for ease of transport (not  shown). Further, the kit can comprise instructions for use  1390.  [0275]  The invention also relates to a binary kit  1400  com› prising a kit container  1410  for the components to prepare a  chemical or biological decontaminant solution. The kit con› tainer  1410  can be, but is not limited to, a suitcase, a box, or  a bucket-type kit container. The kit container  1410  can be, but  is not limited to, a suitcase, a box, or a bucket-type kit con› tainer. The kit container  1410  can be opaque or transparent.  If  transparent, an end user is able to determine if the kit  1400  contains the exact components desired. The kit, or system,  1400  can comprise: (i) a liquid Base Mix  1420,  comprising at  least at least one polar organic amphipathic solvent and a  reactive oxygen species or its source, and (ii) at least one dry  or liquid activator or source thereof  1430.  The solvent(s) can  be a polar aprotic solvent, a polar-protic solvent, or combi› nations thereof. Further, the solvent(s) can be a nitrile, a  ketone, an aldehyde, a carboxylic acid, an amide, a furans, an  alkanol, or a polyol. The volume fraction of water in decon› taminant solution can range from about 25% to about 75%,  and the pH of the solution can less than or equal to about 8.5.  More specifically, the polar amphipathic solvents can be  butanediol, an isomer of butanediol, a linear or branched› chain alcohol with 1 to 15 carbons, an n-alcohol, a butoxy› alcohol, other polyols, or a combination thereof. The active  oxygen species can betetraacetylethylenediamine (TAED) or  tetraacetylmethylenediamine (TAMD). Alternatively, the at  least one reactive oxygen species can comprise peroxyacetic  acid or its source. Alternatively, the pH can be maintained at  less than or equal to about 8.0. The invention is active against  all agents as pH values between about 7.0 to about 10.5; the  Example 11  Example 10 